Sort
48,018 grants matching “immunotherapy”
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$1,049,717Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,049,013Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$1,048,826Scarlett L Gomez · University Of California, San Francisco · R01 · FY2023 · CA
Immunologic Monitoring and Cellular Products Laboratory
$1,048,441Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,047,882Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,047,825Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Clinical Trials of Immunotherapies for Childhood Cancer
$1,047,388Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.
$1,046,868Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · U01 · FY2025 · CA
NON-HUMAN PRIMATE MODELS FOR EVALUATION OF AIDS THERAPIE
$1,046,786Henry M. Jackson Fdn For The Adv Mil/Med · N01 · FY2000 · AI
Cytokines in AIDS and Cancer
$1,046,735George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
DRUGGING THE UNDRUGGABLE: PROGRAMMING OVARIAN CANCER CELLS AS THE NEXT-GENERATION IMMUNOTHERAPY
$1,046,135Dana-Farber Cancer Institute, Inc. · · FY2025 · Defense Health Agency
Developing Immune Based Therapies
$1,045,977Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Clinical Program in Pediatric Sarcomas
$1,045,977Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Biology of T Cell Depletion
$1,045,977Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
$1,045,256Anne S Tsao · University Of Tx Md Anderson Can Ctr · UG1 · FY2023 · CA
Developmental Core
$1,045,062Elizabeth A Klonoff · San Diego State University · U54 · FY2009 · CA
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$1,044,921Claire F Verschraegen · Ohio State University · UG1 · FY2025 · CA
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,044,600Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,044,000Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2017 · CA
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,044,000Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2016 · CA
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,044,000Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2018 · CA
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
$1,044,000Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2020 · CA
Molecular Pharmacology Lab
$1,043,878Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
In vivo delivery of Ab-directed CRISPR ribonucleoproteins for anal cancer immunotherapy
$1,043,843Mary Haak-Frendscho · Spotlight Therapeutics · R44 · FY2023 · CA
UChicago Interdisciplinary Cancer Health Disparities SPORE
$1,043,400Olufunmilayo I Olopade · University Of Chicago · P20 · FY2019 · CA